Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-21T15:06:32.186Z Has data issue: false hasContentIssue false
  • English
  • Français

Low Prevalence of Mupirocin Resistance Among Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Isolates in a Neonatal Intensive Care Unit with an Active Surveillance Cultures and Decolonization Program

Published online by Cambridge University Press:  18 December 2014

Nuntra Suwantarat ,
Karen C. Carroll ,
Tsigereda Tekle ,
Tracy Ross ,
Victor O. Popoola  and
Aaron M. Milstone
Nuntra Suwantarat*
Affiliation:
Division of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, MD
Karen C. Carroll
Affiliation:
Division of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, MD Microbiology Laboratory, Johns Hopkins Hospital, Baltimore, MD
Tsigereda Tekle
Affiliation:
Microbiology Laboratory, Johns Hopkins Hospital, Baltimore, MD
Tracy Ross
Affiliation:
Microbiology Laboratory, Johns Hopkins Hospital, Baltimore, MD
Victor O. Popoola
Affiliation:
Division of Pediatric Infectious Disease, Johns Hopkins University School of Medicine, Baltimore, MD
Aaron M. Milstone
Affiliation:
Division of Pediatric Infectious Disease, Johns Hopkins University School of Medicine, Baltimore, MD Department of Hospital Epidemiology and Infection Control, Johns Hopkins Hospital, Baltimore, MD.
*
Address correspondence to Nuntra Suwantarat, MD, Division of Medical Microbiology, Johns Hopkins University School of Medicine, Meyer B1-193, 600 N. Wolfe St, Baltimore, MD 21287 (nsuwant1@ jhmi.edu).
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Brief
Information
Infection Control & Hospital Epidemiology , Volume 36 , Issue 2 , February 2015 , pp. 232 - 234
Copyright
© 2014 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Patel, JB, Gorwitz, RJ, Jernigan, JA. Mupirocin resistance. Clin Infect Dis 2009;49:935–941.Google Scholar
2. McDanel, JS, Murphy, CR, Diekema, DJ, et al. Chlorhexidine and mupirocin susceptibilities of methicillin-resistant Staphylococcus aureus from colonized nursing home residents. Antimicrob Agents Chemother 2013;57:552–558.Google Scholar
3. Fritz, SA, Hogan, PG, Camins, BC, et al. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob Agents Chemother 2013;57:559–568.Google Scholar
4. Popoola, VO, Budd, A, Wittig, SM, et al. Methicillin-resistant Staphylococcus aureus transmission and infections in a neonatal intensive care unit despite active surveillance cultures and decolonization: challenges for infection prevention. Infect Control Hosp Epidemiol 2014;35:412–418.Google Scholar
5. Huang, YC, Chou, YH, Su, LH, et al. Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics 2006;118:469–474.CrossRefGoogle ScholarPubMed
6. Popoola, VO, Carroll, KC, Ross, T, Reich, NG, Perl, TM, Milstone, AM. Impact of colonization pressure and strain type on methicillin-resistant Staphylococcus aureus transmission in children. Clin Infect Dis 2013;57:1458–1460.Google Scholar
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 24th informational supplement CLSI M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA. 2014.Google Scholar
8. Delaney, HM, Wang, E, Melish, M. Comprehensive strategy including prophylactic mupirocin to reduce Staphylococcus aureus colonization and infection in high-risk neonates. J Perinatol 2013;33:313–318.Google Scholar
9. Hitomi, S, Kubota, M, Mori, N, et al. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. J Hosp Infect 2000;46:123–129.Google Scholar
10. Miller, MA, Dascal, A, Portnoy, J, Mendelson, J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996;17:811–813.Google Scholar